Functional Smart Nanomaterials and Their Theranostics Approaches / edited by Alle Madhusudhan, Shiv Dutt Purohit, Rajendra Prasad, Azamal Husen
Introduction to cancer therapies -- Nanoceria based polymeric composite for theranostic applications -- Functional nanomaterials for bio-sensing applications -- Graphene quantum dots for cancer bioimaging, biosensing and therapy -- "All‐in‐one” nanoparticles for trimodality imaging‐guided intracellular photo‐magnetic hyperthermia therapy under intravenous administration -- State of the art in integrated biosensors for organ-on-a-chip applications -- Nanotherapeutics for Rheumatoid Arthritis Therapy -- Biosensors and Point‐of‐Care Devices for Bacterial Detection: Rapid Diagnostics Informing Antibiotic Therapy -- Nanostructured electrodes as electrochemical biosensors for biomedical applications -- Functional nanomaterials for diagnosis and therapy of male infertility -- Microscopic and spectroscopic characteristic of functional materials -- Functional Biomaterials for targeted drug delivery applications -- Functional materials for multimode therapeutics of solid tumor -- Biomaterials and emerging cancer therapies targeting Tumor Microenvironment -- Next-generation therapies for breast cancer -- Materials for molecular bio-imaging: methods and their characteristics -- Degradation, toxicity and clinical assessment of functional biomedicine -- Clinical validations of localized cancer nanomedicine -- Nano-scavengers in near infrared light mediated photothermal cancer therapy -- Polymer-Drug conjugates: An emerging platform for targeted drug delivery -- Functional biomedicine for image guided therapeutics of solid tumor..
This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms. ..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2024. |
|---|---|
| Erschienen: |
Singapore: Springer Nature Singapore ; 2024. Singapore: Imprint: Springer ; 2024. |
| Ausgabe: |
1st ed. 2024. |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Madhusudhan, Alle [HerausgeberIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Themen: |
|---|
| Umfang: |
1 Online-Ressource(XI, 409 p. 62 illus., 60 illus. in color.) |
|---|
| doi: |
10.1007/978-981-99-6597-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1878700804 |
|---|
| LEADER | 01000nam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1878700804 | ||
| 003 | DE-627 | ||
| 005 | 20240123113203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240123s2024 si |||||o 00| ||eng c | ||
| 020 | |a 9789819965977 |9 978-981-99-6597-7 | ||
| 024 | 7 | |a 10.1007/978-981-99-6597-7 |2 doi | |
| 035 | |a (DE-627)1878700804 | ||
| 035 | |a (DE-599)KEP100306101 | ||
| 035 | |a (DE-He213)978-981-99-6597-7 | ||
| 035 | |a (EBP)100306101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XB-SG | ||
| 072 | 7 | |a TBN |2 bicssc | |
| 072 | 7 | |a TCB |2 bicssc | |
| 072 | 7 | |a SCI010000 |2 bisacsh | |
| 245 | 1 | 0 | |a Functional Smart Nanomaterials and Their Theranostics Approaches |c edited by Alle Madhusudhan, Shiv Dutt Purohit, Rajendra Prasad, Azamal Husen |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Singapore |b Springer Nature Singapore |c 2024. | |
| 264 | 1 | |a Singapore |b Imprint: Springer |c 2024. | |
| 300 | |a 1 Online-Ressource(XI, 409 p. 62 illus., 60 illus. in color.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Smart Nanomaterials Technology | |
| 520 | |a Introduction to cancer therapies -- Nanoceria based polymeric composite for theranostic applications -- Functional nanomaterials for bio-sensing applications -- Graphene quantum dots for cancer bioimaging, biosensing and therapy -- "All‐in‐one” nanoparticles for trimodality imaging‐guided intracellular photo‐magnetic hyperthermia therapy under intravenous administration -- State of the art in integrated biosensors for organ-on-a-chip applications -- Nanotherapeutics for Rheumatoid Arthritis Therapy -- Biosensors and Point‐of‐Care Devices for Bacterial Detection: Rapid Diagnostics Informing Antibiotic Therapy -- Nanostructured electrodes as electrochemical biosensors for biomedical applications -- Functional nanomaterials for diagnosis and therapy of male infertility -- Microscopic and spectroscopic characteristic of functional materials -- Functional Biomaterials for targeted drug delivery applications -- Functional materials for multimode therapeutics of solid tumor -- Biomaterials and emerging cancer therapies targeting Tumor Microenvironment -- Next-generation therapies for breast cancer -- Materials for molecular bio-imaging: methods and their characteristics -- Degradation, toxicity and clinical assessment of functional biomedicine -- Clinical validations of localized cancer nanomedicine -- Nano-scavengers in near infrared light mediated photothermal cancer therapy -- Polymer-Drug conjugates: An emerging platform for targeted drug delivery -- Functional biomedicine for image guided therapeutics of solid tumor. | ||
| 520 | |a This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms. . | ||
| 650 | 0 | |a Nanobiotechnology. | |
| 650 | 0 | |a Biomedical engineering. | |
| 650 | 0 | |a Nanoparticles. | |
| 700 | 1 | |a Madhusudhan, Alle |e herausgeberin |4 edt | |
| 700 | 1 | |a Purohit, Shiv Dutt |e herausgeberin |4 edt | |
| 700 | 1 | |a Prasad, Rajendra |e herausgeberin |4 edt | |
| 700 | 1 | |a Husen, Azamal |e herausgeberin |4 edt | |
| 776 | 1 | |z 9789819965960 | |
| 776 | 1 | |z 9789819965984 | |
| 776 | 1 | |z 9789819965991 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819965960 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819965984 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789819965991 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-99-6597-7 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 912 | |a ZDB-2-SEB |b 2024 | ||
| 912 | |a ZDB-2-CMS |b 2024 | ||
| 912 | |a ZDB-2-SXC |b 2024 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a ISIL_DE-830 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a ISIL_DE-705 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a ISIL_DE-700 | ||
| 912 | |a GBV_ILN_132 | ||
| 912 | |a ISIL_DE-959 | ||
| 912 | |a GBV_ILN_153 | ||
| 912 | |a ISIL_DE-Ha94 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a ISIL_DE-14 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a ISIL_DE-90 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a ISIL_DE-93 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 912 | |a GBV_ILN_2020 | ||
| 912 | |a ISIL_DE-Ch1 | ||
| 912 | |a GBV_ILN_2027 | ||
| 912 | |a ISIL_DE-105 | ||
| 912 | |a GBV_ILN_2034 | ||
| 912 | |a ISIL_DE-Rt2 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a ISIL_DE-944 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 620.5 | ||
| 953 | |2 045F |a 660.6 | ||
| 980 | |2 23 |1 01 |x 0830 |b 4467593217 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h olr-springer |u i |y z |z 25-01-24 | ||
| 980 | |2 60 |1 01 |x 0705 |b 4467587144 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h SpringerLink |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |k Nur für Angehörige der HSU: Volltextzugang von außerhalb des Campus mit Anmeldung über Shibboleth mit Ihrer Bibliothekskennung |y z |z 25-01-24 | ||
| 980 | |2 62 |1 01 |x 0028 |b 446769448X |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 25-01-24 | ||
| 980 | |2 65 |1 01 |x 0003 |b 4467698000 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-CMS |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 25-01-24 | ||
| 980 | |2 120 |1 01 |x 0715 |b 450657611X |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 03-04-24 | ||
| 980 | |2 130 |1 01 |x 0700 |b 4467626476 |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 25-01-24 | ||
| 980 | |2 132 |1 01 |x 0959 |b 4493380993 |h OLR-ESP-CMS |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k |z 28-02-24 | ||
| 980 | |2 153 |1 01 |x 3315 |b 4489892705 |h OLR-ESP |k Full text access is limited to MPI staff and may be printed or saved solely for private use or for research purposes. You are not allowed to pass articles (electronically or printed) to a third party. Systematic download is prohibited |y z |z 21-02-24 | ||
| 980 | |2 2006 |1 01 |x DE-14 |b 446639041X |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 23-01-24 | ||
| 980 | |2 2014 |1 01 |x DE-90 |b 4466390436 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 23-01-24 | ||
| 980 | |2 2015 |1 01 |x DE-93 |b 4467413472 |c 00 |f --%%-- |d --%%-- |e --%%-- |j p |k Campuslizenz |y l01 |z 24-01-24 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 4466390460 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 23-01-24 | ||
| 980 | |2 2020 |1 01 |x DE-Ch1 |b 4466390487 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |k Campuslizenz |y l01 |z 23-01-24 | ||
| 980 | |2 2027 |1 01 |x DE-105 |b 4466360685 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Campuslizenz |y l01 |z 23-01-24 | ||
| 980 | |2 2034 |1 01 |x DE-Rt2 |b 4466360715 |c 00 |f --%%-- |d eBook |e --%%-- |j n |k Zugriff von allen im Hochschulnetz befindlichen Rechnern; Hochschulangehörige können auch über VPN von außerhalb des Campusnetzes zugreifen |y l01 |z 23-01-24 | ||
| 980 | |2 2111 |1 01 |x DE-944 |b 446636074X |c 00 |f --%%-- |d E-Book Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 23-01-24 | ||
| 981 | |2 23 |1 01 |x 0830 |y Springer EBook |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 60 |1 01 |x 0705 |y Volltextzugang Campus |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016407238003501 | ||
| 981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 132 |1 01 |x 0959 |y Zugriff nur für Angehörige der Hochschule Osnabrück im Hochschulnetz |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 153 |1 01 |x 3315 |y Springer EBook |r https://doi.org/10.1007/978-981-99-6597-7?nols=y | ||
| 981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 2020 |1 01 |x DE-Ch1 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 2034 |1 01 |x DE-Rt2 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 981 | |2 2111 |1 01 |x DE-944 |r https://doi.org/10.1007/978-981-99-6597-7 | ||
| 982 | |2 132 |1 01 |x 0959 |8 00 |a EBooks Springer Chemistry & Materials Science | ||
| 982 | |2 2027 |1 01 |x DE-105 |8 00 |s s |a ebook | ||
| 983 | |2 2111 |1 01 |x DE-944 |8 00 |0 (DE-627)1353370437 |a e-Book | ||
| 995 | |2 23 |1 01 |x 0830 |a olr-springer | ||
| 995 | |2 60 |1 01 |x 0705 |a SpringerLink | ||
| 995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-CMS | ||
| 995 | |2 120 |1 01 |x 0715 |a alma | ||
| 995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP-CMS | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-ESP | ||
| 995 | |2 153 |1 01 |x 3315 |a OLR-ESP | ||
| 998 | |2 23 |1 01 |x 0830 |0 2024.01.25 | ||